tiprankstipranks
Advertisement

INTF - ETF AI Analysis

Compare

Top Page

INTF

iShares MSCI Intl Multifactor ETF (INTF)

Rating:64Neutral
Price Target:
INTF, the iShares MSCI Intl Multifactor ETF, earns a solid rating largely because it holds high-quality global leaders like Novartis, AstraZeneca, ASML, and HSBC, which show strong financial performance, positive earnings commentary, and generally supportive technical trends. These strengths are slightly offset by names like BHP, where short-term bearish momentum, and holdings facing valuation or overbought concerns, introduce some risk, along with the broader exposure to sector- and region-specific factors that can affect international markets.
Positive Factors
Strong Recent Performance
The ETF has shown solid gains so far this year and in recent months, indicating positive momentum.
Global Diversification
Holdings spread across many countries such as Japan, the UK, the U.S., and Europe help reduce the impact of weakness in any single market.
Low Expense Ratio
The fund’s relatively low annual fee means more of the investment returns stay in investors’ pockets over time.
Negative Factors
Mixed Top Holding Performance
While several top positions have delivered strong gains, a few key holdings have been weak, which can drag on overall returns.
Heavy Japan and Europe Exposure
A large share of assets in Japan and major European markets means the fund is sensitive to economic or political issues in those regions.
Financial Sector Dependence
Significant exposure to financial companies increases the fund’s vulnerability to banking and interest-rate related risks.

INTF vs. SPDR S&P 500 ETF (SPY)

INTF Summary

The iShares MSCI Intl Multifactor ETF (INTF) tracks the STOXX International Equity Factor index and invests in a wide mix of companies outside the U.S., across countries like Japan, the UK, and Europe. It holds many well-known names such as Nestlé and AstraZeneca, and spreads money across financials, industrials, health care, and more. The fund looks for stocks with traits like solid quality, reasonable prices, and strong recent performance, aiming for better long-term growth and diversification than a simple market fund. A key risk is that international stocks can be volatile and may rise or fall with global markets and currency swings.
How much will it cost me?The iShares MSCI Intl Multifactor ETF (INTF) has an expense ratio of 0.16%, which means you’ll pay $1.60 per year for every $1,000 invested. This is lower than average because it’s passively managed, focusing on tracking a multifactor index rather than active stock selection.
What would affect this ETF?The iShares MSCI Intl Multifactor ETF (INTF) could benefit from growth in developed markets outside the U.S., especially if sectors like financials and technology perform well, as they make up a significant portion of the fund. However, challenges such as rising interest rates or economic slowdowns in these regions could negatively impact key holdings like Novartis and ASML, as well as broader sector performance. Regulatory changes or geopolitical tensions in developed markets may also influence the ETF's future returns.

INTF Top 10 Holdings

INTF’s story is driven by a handful of global heavyweights outside the U.S. ASML is doing the heavy lifting, with rising momentum that gives the fund a strong tech tailwind, while ABB and BHP are also powering ahead from the industrial and materials side. Big banks like Royal Bank of Canada and HSBC are adding steady fuel, reflecting the ETF’s meaningful tilt toward financials. On the softer side, defensives such as Roche and Nestlé have been more mixed to lagging, acting as a mild brake on an otherwise broadly rising developed-markets ex-U.S. portfolio.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
ASML Holding NV2.12%$70.71M€477.33B106.32%
76
Outperform
Novartis AG2.05%$68.46MCHF207.57B22.14%
80
Outperform
ABB Ltd1.09%$36.45MCHF140.24B78.92%
78
Outperform
Royal Bank Of Canada1.07%$35.74M$245.63B48.99%
75
Outperform
Roche Holding AG1.04%$34.69M$327.04B22.13%
73
Outperform
Nestlé SA1.02%$33.86MCHF205.30B-1.29%
71
Outperform
HSBC Holdings0.99%$33.15M£226.99B58.35%
80
Outperform
AstraZeneca0.95%$31.69M$292.69B32.74%
80
Outperform
BHP Group Ltd0.92%$30.82MAU$285.03B66.90%
68
Neutral
Rio Tinto Limited0.85%$28.24MAU$238.86B80.75%
78
Outperform

INTF Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
40.00
Positive
100DMA
39.48
Positive
200DMA
37.38
Positive
Market Momentum
MACD
0.27
Positive
RSI
55.11
Neutral
STOCH
47.95
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For INTF, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 40.82, equal to the 50-day MA of 40.00, and equal to the 200-day MA of 37.38, indicating a bullish trend. The MACD of 0.27 indicates Positive momentum. The RSI at 55.11 is Neutral, neither overbought nor oversold. The STOCH value of 47.95 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for INTF.

INTF Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$3.42B0.16%
64
Neutral
$5.61B0.25%
65
Neutral
$4.76B0.40%
70
Outperform
$3.79B0.30%
68
Neutral
$3.51B0.25%
69
Neutral
$2.73B0.43%
61
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
INTF
iShares MSCI Intl Multifactor ETF
40.88
9.18
28.96%
GSIE
Goldman Sachs ActiveBeta International Equity ETF
LVHI
Legg Mason International Low Volatility High Dividend ETF
IMTM
iShares MSCI Intl Momentum Factor ETF
IDMO
Invesco S&P International Developed Momentum ETF
PXF
Invesco FTSE RAFI Developed Markets ex-U.S. ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement